Latka logo

Valuation

$20.4M

2025 Revenue

$6.8M

Funding

$0

Founded

2024

Kyron Medical Revenue & Valuation (2025)

Kyron’s healthcare‑grade agents triage denials, draft appeals, and reconcile claims, so your team can spend more time with patients, not paperwork.

Last updated

Kyron Medical Revenue

In 2025, Kyron Medical's revenue reached $6.8M. The company previously reported $6.8M in 2025. Since its launch in 2024, Kyron Medical has shown consistent revenue growth.

Kyron Medical Revenue GrowthReported revenue / ARR over time$0$1.5M$3M$4.5M$6M$7.5M20242025$0$6.8MSource: GetLatka.com
YearMilestoneSource
2025Kyron Medical Hit $6.8m revenue in September 2025
2025Kyron Medical Hit $6.8m revenue in September 2025
2024Launched with $0 revenue

Kyron Medical Valuation, Funding Rounds

Kyron Medical reached a $20.4M valuation in 2025, set during its M&A Offer round.

Kyron Medical Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$5M$0.2$10M$0.4$15M$0.6$20M$0.8$25M$120242025$20.4MSource: GetLatka.com
YearRoundAmountValuation% SoldSource
2025M&A Offer-$20.4M-

Founder / CEO

We don't have Kyron Medical's Founder / CEO on record yet.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Kyron Medical yet.

Kyron Medical Employees & Team Size

We do not have information about Kyron Medical's team yet.

Frequently Asked Questions about Kyron Medical

What is Kyron Medical's revenue?

Kyron Medical generates $6.8M in revenue.

How much funding does Kyron Medical have?

Kyron Medical raised $0.

Where is Kyron Medical headquarters?

Kyron Medical is headquartered in United States.

Compare Kyron Medical to the industry

Kyron Medical operates across multiple industries. Browse revenue, funding, and growth data for Kyron Medical in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile